Enhancing encapsulation of filarial antigen Brugia malayi thioredoxin in nano-liposomes: The role of lecithin composition

Background and purpose: Lymphatic filariasis is a debilitating infectious disease prevalent in endemic areas, necessitating the development of an effective vaccine for eradication. Although recombinant vaccine candidates have been deemed safe, they often fail to provide sufficient protection, which...

Full description

Saved in:
Bibliographic Details
Main Authors: Malathi Balasubramaniyan (Author), Vimalraj Vinayagam (Author), Moni Philip Jacob Kizhakedathil (Author), Kaliraj Perumal (Author)
Format: Book
Published: International Association of Physical Chemists (IAPC), 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f5b6a656ee3544f1a1bf0440ec4aa20c
042 |a dc 
100 1 0 |a Malathi Balasubramaniyan  |e author 
700 1 0 |a Vimalraj Vinayagam  |e author 
700 1 0 |a Moni Philip Jacob Kizhakedathil  |e author 
700 1 0 |a Kaliraj Perumal  |e author 
245 0 0 |a Enhancing encapsulation of filarial antigen Brugia malayi thioredoxin in nano-liposomes: The role of lecithin composition 
260 |b International Association of Physical Chemists (IAPC),   |c 2023-11-01T00:00:00Z. 
500 |a 10.5599/admet.2089 
500 |a 1848-7718 
520 |a Background and purpose: Lymphatic filariasis is a debilitating infectious disease prevalent in endemic areas, necessitating the development of an effective vaccine for eradication. Although recombinant vaccine candidates have been deemed safe, they often fail to provide sufficient protection, which can be overcome by encapsulating them in nano-liposomes. In this study, we have optimised the liposomal composition for enhanced stability and encapsulation of filarial antigen Brugia malayi thioredoxin (Bm-TRX). Experimental approach: Nano-liposomes were prepared using egg phosphatidylcholine (EPC) and cholesterol via thin-film hydration, followed by sonication and characterizing. Encapsulation efficiency was optimised using different weight ratios of EPC to cholesterol (8:2, 7:3, and 6:4) and total lipid (EPC+Cholesterol) concentration to antigen Bm-TRX (10:1, 10:2, and 10:3) followed by release kinetics study. Key results: Optimised parameters yielded spherical liposomes measuring 209 nm in diameter with narrow polydispersity. Our findings demonstrated the highest encapsulation efficiency of 70.685 % and stability of 10 hours for an EPC to cholesterol weight ratio of 7:3. The in silico study proved the antigenic nature of TRX. Conclusion: The liposomal formulations loaded with TRX, as optimized in this study, hold promise for improving antigen efficiency by enhancing stability, bioavailability, and prophylactic effects by acting as immune potentiators. 
546 |a EN 
690 |a liposome 
690 |a lymphatic filariasis 
690 |a thioredoxin 
690 |a egg phosphatidylcholine 
690 |a cholesterol 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n ADMET and DMPK (2023) 
787 0 |n https://pub.iapchem.org/ojs/index.php/admet/article/view/2089 
787 0 |n https://doaj.org/toc/1848-7718 
856 4 1 |u https://doaj.org/article/f5b6a656ee3544f1a1bf0440ec4aa20c  |z Connect to this object online.